{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0017812/ORPHA:314662","label":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","mondoId":"MONDO:0017812","onsetQualifier":null,"recordKeys":["008e85deac51a485506e58510836c5cf205e604a00857e5c231caa42a0c1ffd2","320e593e2beefc6e14f834b8b2e1363734cd1bc14ad6012fda7e21efd20db323","38a7c47e7da36c21b3f02a6eaa7fa381a3ce30f33a7e66a70742466a030f1614","3b396f014688b68662ecd6a9b1ea6d6e005fad3c5caedb374282280291182bdc","3e156a0c5cd5bf5c1883187863e41e9c809eba17bcbe9c121136d13acf470383","4915abefa4f2898beab9b40b1835d1b403cb8800b6162c797aa341dd1abfded4","54733729774e81f6daa48b13d6a08cf6e12d389bfda05219d3aada7c1e823491","724f40c8134b6044c4c0e0d3b7874568978644933871dcaee1f4a1077fee0d84","883105c64c3d0d8f2db18e265e300203388ef11de9dc0e121e1e666f91c33151","9f8eb36383d38e12044b74428eeee5eb4bc7c5485e93c8ad49092e563480a636","d77c55ae0f344f917657154795e2f67b388846adc3029fcfa35d91a9cd8f62d9","e4c95c6fa925d1e84b522c1c2bf88c1d94bc8bdd399d870442d3688be3685e91","f235de430fa2109e1be2278511c7f320bdd8330f11d99933a2bbcbfe9ced79ca","fb870e19e5a05b2e4881b2dff06ec0357a3d0eb2afaf2d03f03803be57a26352"],"recordQualifiers":{},"scopeLabel":"ORPHA:314662","sourceIds":["ORPHA:314662"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0017812/ORPHA:314662"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":14,"sourceGroups":{"omim":0,"orphanet":14,"published":0}},"features":[{"hpoId":"HP:0025104","label":"Capillary malformation","primary":false},{"hpoId":"HP:0002019","label":"Constipation","primary":false},{"hpoId":"HP:0012725","label":"Cutaneous syndactyly","primary":false},{"hpoId":"HP:0010816","label":"Epidermal nevus","primary":false},{"hpoId":"HP:0030424","label":"Epididymal cyst","primary":false},{"hpoId":"HP:0000034","label":"Hydrocele testis","primary":false},{"hpoId":"HP:0100774","label":"Hyperostosis","primary":false},{"hpoId":"HP:0009126","label":"Increased adipose tissue","primary":false},{"hpoId":"HP:0100578","label":"Lipoatrophy","primary":false},{"hpoId":"HP:0012032","label":"Lipoma","primary":false},{"hpoId":"HP:0100559","label":"Lower limb asymmetry","primary":false},{"hpoId":"HP:0001548","label":"Overgrowth","primary":false},{"hpoId":"HP:0010442","label":"Polydactyly","primary":false},{"hpoId":"HP:0011276","label":"Vascular skin abnormality","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0017812","records":[{"frequencyKind":"range","key":"008e85deac51a485506e58510836c5cf205e604a00857e5c231caa42a0c1ffd2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012725","is_excluded":false,"label":"Cutaneous syndactyly","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"320e593e2beefc6e14f834b8b2e1363734cd1bc14ad6012fda7e21efd20db323","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010816","is_excluded":false,"label":"Epidermal nevus","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"38a7c47e7da36c21b3f02a6eaa7fa381a3ce30f33a7e66a70742466a030f1614","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002019","is_excluded":false,"label":"Constipation","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b396f014688b68662ecd6a9b1ea6d6e005fad3c5caedb374282280291182bdc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009126","is_excluded":false,"label":"Increased adipose tissue","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3e156a0c5cd5bf5c1883187863e41e9c809eba17bcbe9c121136d13acf470383","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010442","is_excluded":false,"label":"Polydactyly","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4915abefa4f2898beab9b40b1835d1b403cb8800b6162c797aa341dd1abfded4","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025104","is_excluded":false,"label":"Capillary malformation","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"54733729774e81f6daa48b13d6a08cf6e12d389bfda05219d3aada7c1e823491","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100559","is_excluded":false,"label":"Lower limb asymmetry","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"724f40c8134b6044c4c0e0d3b7874568978644933871dcaee1f4a1077fee0d84","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030424","is_excluded":false,"label":"Epididymal cyst","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"883105c64c3d0d8f2db18e265e300203388ef11de9dc0e121e1e666f91c33151","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100774","is_excluded":false,"label":"Hyperostosis","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9f8eb36383d38e12044b74428eeee5eb4bc7c5485e93c8ad49092e563480a636","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100578","is_excluded":false,"label":"Lipoatrophy","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d77c55ae0f344f917657154795e2f67b388846adc3029fcfa35d91a9cd8f62d9","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0001548","is_excluded":false,"label":"Overgrowth","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e4c95c6fa925d1e84b522c1c2bf88c1d94bc8bdd399d870442d3688be3685e91","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012032","is_excluded":false,"label":"Lipoma","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f235de430fa2109e1be2278511c7f320bdd8330f11d99933a2bbcbfe9ced79ca","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011276","is_excluded":false,"label":"Vascular skin abnormality","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fb870e19e5a05b2e4881b2dff06ec0357a3d0eb2afaf2d03f03803be57a26352","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:314662","disease_name":"Segmental progressive overgrowth syndrome with fibroadipose hyperplasia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000034","is_excluded":false,"label":"Hydrocele testis","onset_id":null,"reference":"ORPHA:314662","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"segmental-progressive-overgrowth-syndrome-with-fibroadipose-hyperplasia","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"segmental progressive overgrowth syndrome with fibroadipose hyperplasia"},"schemaVersion":1}